Pathology of Bone: Changes Associated With Different Classes of Compounds

Area of Science:

• Pharmacology
• Bone Biology
• Endocrinology

Background:

• Drug-induced bone toxicity is a significant clinical concern.
• Various therapeutic agents can adversely affect skeletal homeostasis.
• Understanding these effects is vital for patient safety.

Purpose of the Study:

• To comprehensively review the diverse effects of different drug classes on bone metabolism.
• To elucidate the mechanisms by which drugs influence bone formation and resorption.
• To highlight potential risks such as impaired growth and bone necrosis.

Main Methods:

• Literature review of studies investigating drug effects on bone.
• Analysis of data on endochondral ossification and growth factor pathways.
• Categorization of observed bone effects based on drug class.

Main Results:

• Identified drug classes that inhibit endochondral ossification and the growth hormone-insulin-like growth factor 1 axis.
• Documented agents that promote or inhibit bone formation and resorption.
• Observed instances of abnormal bone formation and drug-induced bone necrosis.

Conclusions:

• Drug effects on bone are multifaceted, ranging from growth inhibition to altered remodeling.
• Careful consideration of skeletal side effects is necessary when prescribing medications.
• Further research is warranted to mitigate bone-related adverse events from drug therapies.